MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0003111
Nectar Biopharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.6 Cr
▼ 38% YoY
Net profit · FY 2025
₹74.56 Lakh
Net margin 28.7%
EBITDA · FY 2025
₹1.29 Cr
EBITDA margin 49.8%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Satisfied charges
₹22.65 Cr
No open charges
Company age
11 yrs
Est. 2015
Employees · EPFO
2
Provident fund records
About Nectar Biopharma Private Limited
Data last updated:
Nectar Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2015PTC314118. Its GSTIN is 27AAECN9006E1ZL (Maharashtra). The company holds 13 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Rajinder Sharma and Aryan Goyal.
Its last annual general meeting (AGM) was held on 16 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No.101 1st Floor Udyog Bhavan Sonawala Lane Goregaon East, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.6 Cr, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹74.56 Lakh (net margin 28.7%) and EBITDA of ₹1.29 Cr (EBITDA margin 49.8%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 48% over five years.
The company has about 2 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Nectar Biopharma. As per MCA filings, the company has satisfied charges of ₹22.65 Cr on record. Court records list 84 cases involving the company, including 75 filed by the company and 9 filed against it; 9 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2019. Its 3 peer companies in the Pharma industry (Biopharma, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is French Remedies Private Limited with revenue of ₹2.6 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2020, listing 43 overdue payments to 12 micro and small suppliers.
Nectar Biopharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0003111). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website necbio.com.
Company details
CIN U24100MH2015PTC314118
Registration Number 314118
Incorporation Date 13 April 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 16 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-CH-01-0003111
CIN history
Nectar Biopharma has one previous CIN (Corporate Identification Number): U24100DL2015PTC278972. The current CIN is U24100MH2015PTC314118, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH2015PTC314118 | Current |
| U24100DL2015PTC278972 | Previous |
Recognitions & Rankings of Nectar Biopharma
Contact details
Nectar Biopharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is necbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.101 1st Floor Udyog Bhavan Sonawala Lane Goregaon East, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nectar Biopharma Private Limited, buy the company report.
Comprehensive company report
Nectar Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nectar Biopharma operates one associated brand: Nectar Biopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Markets prescription drugs, OTC products, and medical solutions globally. | necbio.com |
Business activity
The main business activity of Nectar Biopharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nectar Biopharma Private Limited, buy the company report.
Financials of Nectar Biopharma Private Limited
FY 2024 filings availableNectar Biopharma Private Limited reported revenue of ₹2.6 Cr (down 38% YoY) for FY 2025.
Revenue · FY 2025
₹2.6 Cr ▼ 38%
Net profit · FY 2025
₹74.56 Lakh margin 28.7%
EBITDA · FY 2025
₹1.29 Cr margin 49.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 16%
5 years · compounded
▼ 48%
EBITDA CAGR growth
1 year
▼ 58%
3 years · compounded
▲ 1%
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 38% fall in the latest year. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49.8% | ||||
| Net Profit Margin | 28.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nectar Biopharma Private Limited, buy the company report.
Board of directors of Nectar Biopharma Private Limited
Nectar Biopharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajinder Sharma Also directs: Nureca Technologies Private Limited, Nureca Limited | Director | 25 Jul 2022 | 4 Years 2 Months | Current |
| Aryan Goyal Also directs: Vivaviva Private Limited, Trumom Private Limited, Nureca Technologies Private Limited and 2 more | Director | 27 Sep 2021 | 5 Years 0 Months | Current |
| Saurabh Goyal Also directs: Trumom Private Limited, Nureca Technologies Private Limited, Rhinobeet Private Limited and 2 more | Director | 14 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Nectar Biopharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Biopharma, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| French Remedies Private Limited | ₹2.6 Cr (FY 2024) | 40.0% | Lucknow, Uttar Pradesh, India | |||
| Nectar Biopharma Private Limitedthis company | ₹2.6 Cr (FY 2025) | ₹74.56 Lakh | 28.7% | -38.0% | 2 | Mumbai, Maharashtra, India |
| Wellcuring Lifesciences Private Limited | ₹2.59 Cr (FY 2025) | -3.0% | Haldwani, Uttarakhand, India | |||
| Ketan Pharma Chem Private Limited | ₹2.58 Cr (FY 2024) | 1272.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Nectar Biopharma Private Limited, buy the company report.
Auditor
Nectar Biopharma Private Limited is audited by MUKESH VISHESH AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH VISHESH AND ASSOCIATES | FY 2024 | 016344N |
Shareholding
The shareholding of Nectar Biopharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nectar Biopharma Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹22.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2019 | 100308286 | Hdfc Bank Limited | ₹14.5 Lakh | Satisfied | |
| 26 Feb 2019 | 100254651 | Others | ₹22.5 Cr | Satisfied |
To see the full charge records of Nectar Biopharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Nectar Biopharma Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2019.
Total deals
3
Secondary share transfers
2
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
| Apr 2016 | Rights issue | ₹49 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nectar Biopharma Private Limited has 84 court cases on record: 75 filed by Nectar Biopharma, 9 filed against it. 9 cases are pending and 75 are disposed.
Total cases
84
Filed by the company
75
Filed against the company
9
Pending
9
Disposed
75
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 65 | 2 | 6 |
| High courts | 17 | 5 | 3 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 84)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Daredia Lifesciences Private Limited & Ors. | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Mankind Pharma Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Franco-Indian Pharmaceuticals Private Limited | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against Meclon Pharmaceuticals Pvt Ltd | Disposed |
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed by the company against Meclon Pharmaceuticals Pvt Ltd | Disposed |
To see the full case history of Nectar Biopharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Nectar Biopharma Private Limited was last rated by Crisil on 26 Oct 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 26 Oct 2018 |
To see the full credit ratings and regulatory alerts of Nectar Biopharma Private Limited, buy the company report.
MSME payment delays
Nectar Biopharma Private Limited has 5 MSME Form 1 returns on record between 2019 and 2020, listing 43 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hillson Health Care | |||
| Pinnacle Life Science Private Limited | |||
| Shree Dhanwantri Herbal | |||
| National Laboratories (Unit-Ii) | |||
| Kingston Aqua Industries Private Limited. |
To see the full MSME payment records of Nectar Biopharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Nectar Biopharma has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Trumom Private Limited | U24290DL2016PTC307027 |
To see the full group structure of Nectar Biopharma Private Limited, buy the company report.
Employees & EPFO
Nectar Biopharma Private Limited has a workforce of 2 employees on its EPFO records as of Mar 05, 2025, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
Employee growth
-96.23%
GST
Nectar Biopharma has 13 GST registrations: 4 active and 9 cancelled or inactive.
Total GSTINs
13
Active
4
Cancelled / inactive
9
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECN9006E1ZL | Maharashtra | Active | 21 Sep 2017 |
| 03AAECN9006E1ZV | Punjab | Active | 01 Jul 2017 |
| 06AAECN9006E1ZP | Haryana | Active | 01 Jul 2017 |
| 04AAECN9006E1ZT | Chandigarh | Active | 17 May 2019 |
To see the full GST registrations and return filing status of Nectar Biopharma Private Limited, buy the company report.
Recent activity
Nectar Biopharma Private Limited has 12 board changes on record since 2016: 3 appointments and 9 cessations. The latest: Rajinder Sharma ceased to be Additional Director on 30 Sep 2022.
Charges
A charge registered on 04 Dec 2019 via Charge ID 100308286 with Hdfc Bank Limited was fully satisfied on 10 Dec 2024.
AGM
Nectar Biopharma Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records.
Filing
Nectar Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Rajinder Sharma ceased to be Additional Director.
Appointed
Rajinder Sharma was appointed as Director.
Ceased
Aryan Goyal ceased to be Additional Director.
Ceased
Rajneesh Kaushal ceased to be Additional Director.
Ceased
Santosh Kumar Srivastava ceased to be Additional Director.
Appointed
Aryan Goyal was appointed as Director.
Charges
A charge registered on 26 Feb 2019 via Charge ID 100254651 with Others was fully satisfied on 26 Mar 2021.
Charges
A charge with Others of Rs. 22.50 Cr registered on 26 Feb 2019 with Charge ID 100254651 was modified on 10 Feb 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100308286 was registered on 04 Dec 2019.
8 earlier events are in the company report.
Frequently asked questions
Nectar Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 April 2015 (11+ years old) and is registered under CIN U24100MH2015PTC314118.
Nectar Biopharma has 3 current directors:
- Rajinder Sharma - Director
- Aryan Goyal - Director
- Saurabh Goyal - Director
The latest financial statements of Nectar Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 16 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Nectar Biopharma is 27AAECN9006E1ZL, registered in Maharashtra. The company has 13 GST registrations in all, of which 4 are active and 9 are cancelled or inactive. Other active GSTINs include 03AAECN9006E1ZV (Punjab), 06AAECN9006E1ZP (Haryana), 04AAECN9006E1ZT (Chandigarh).
The CIN (Corporate Identification Number) of Nectar Biopharma is U24100MH2015PTC314118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nectar Biopharma has 84 court cases on record: 75 filed by the company and 9 filed against it. 9 are pending. Most are in the district courts.
Nectar Biopharma was incorporated on 13 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Nectar Biopharma has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2019.
The peers of Nectar Biopharma by revenue are French Remedies Private Limited, Wellcuring Lifesciences Private Limited, Ketan Pharma Chem Private Limited, all in the Pharma industry (Biopharma, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajinder Sharma ceased to be Additional Director on 30 Sep 2022. Rajinder Sharma was appointed as Director on 25 Jul 2022. Aryan Goyal ceased to be Additional Director on 30 Nov 2021. Nectar Biopharma has 12 board changes on record in total.
Yes, Nectar Biopharma is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0003111).
Nectar Biopharma has 5 MSME Form 1 returns on record between 2019 and 2020, listing 43 overdue payments to 12 micro and small suppliers. The latest return was filed on 15 Jul 2020.